Literature DB >> 26577717

Type 2 diabetes via β-cell dysfunction in east Asian people.

Daisuke Yabe1, Yutaka Seino2.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26577717     DOI： 10.1016/S2213-8587(15)00389-7

Source DB:  PubMed          Journal:  Lancet Diabetes Endocrinol        ISSN： 2213-8587            Impact factor:   32.069


× No keyword cloud information.
  32 in total

1.  A polysaccharide extract from the medicinal plant Maidong inhibits the IKK-NF-κB pathway and IL-1β-induced islet inflammation and increases insulin secretion.

Authors:  Dandan Mao; Xiao Yu Tian; Di Mao; Sze Wan Hung; Chi Chiu Wang; Clara Bik San Lau; Heung Man Lee; Chun Kwok Wong; Elaine Chow; Xing Ming; Huanyi Cao; Ronald C Ma; Paul K S Chan; Alice P S Kong; Joshua J X Li; Guy A Rutter; Wing Hung Tam; Juliana C N Chan
Journal:  J Biol Chem       Date:  2020-06-30       Impact factor: 5.157

2.  SUSTAINable management of type 2 diabetes: feasibility of use and safety of semaglutide.

Authors:  Jun Shirakawa; Yasuo Terauchi
Journal:  Ann Transl Med       Date:  2018-04

3.  Assessment of Cardiovascular Risk Factors in Patients with Type 2 Diabetes in Upper Egypt Villages.

Authors:  Ahmed Hussein; Sharaf E D Mahmoud; Mohammad Shafiq Awad; Hossam Eldin M Mahmoud
Journal:  Diabetes Metab Syndr Obes       Date:  2020-12-03       Impact factor: 3.168

4.  A randomized, placebo-controlled trial to assess the efficacy and safety of sitagliptin in Japanese patients with type 2 diabetes and inadequate glycaemic control on ipragliflozin.

Authors:  Yutaka Seino; Kohei Kaku; Takashi Kadowaki; Taro Okamoto; Asako Sato; Masayoshi Shirakawa; Edward A O'Neill; Samuel S Engel; Keith D Kaufman
Journal:  Diabetes Obes Metab       Date:  2021-02-28       Impact factor: 6.577

5.  Efficacy and safety of once-weekly semaglutide in Japanese individuals with type 2 diabetes by baseline age and body mass index.

Authors:  Daisuke Yabe; Yuichiro Yamada; Kohei Kaku; Tomoyuki Nishida; Toshihiro Sato; Yutaka Seino
Journal:  J Diabetes Investig       Date:  2022-03-09       Impact factor: 3.681

6.  Protocol for the specialist supervised individualised multifactorial treatment of new clinically diagnosed type 2 diabetes in general practice (IDA): a prospective controlled multicentre open-label intervention study.

Authors:  Jacob Volmer Stidsen; Jens Steen Nielsen; Jan Erik Henriksen; Søren Gunnar Friborg; Reimar Wernich Thomsen; Thomas Bastholm Olesen; Michael Hecht Olsen; Henning Beck-Nielsen
Journal:  BMJ Open       Date:  2017-12-10       Impact factor: 2.692

7.  Single-cell transcriptomics of East-Asian pancreatic islets cells.

Authors:  Rajkumar Dorajoo; Yusuf Ali; Vanessa S Y Tay; Jonathan Kang; Sudhagar Samydurai; Jianjun Liu; Bernhard O Boehm
Journal:  Sci Rep       Date:  2017-07-10       Impact factor: 4.379

8.  Diabetes self-assessment score and the development of diabetes: A 10-year prospective study.

Authors:  Gyuri Kim; Yong-Ho Lee; Byung-Wan Lee; Eun Seok Kang; In-Kyu Lee; Bong-Soo Cha; Dae Jung Kim
Journal:  Medicine (Baltimore)       Date:  2017-06       Impact factor: 1.889

9.  Body mass index trajectory patterns and changes in visceral fat and glucose metabolism before the onset of type 2 diabetes.

Authors:  Keisuke Kuwahara; Toru Honda; Tohru Nakagawa; Shuichiro Yamamoto; Takeshi Hayashi; Tetsuya Mizoue
Journal:  Sci Rep       Date:  2017-03-07       Impact factor: 4.379

10.  Impact of metabolic syndrome on the incidence of type 2 diabetes in middle-aged Japanese individuals with impaired insulin secretion: the Saku study.

Authors:  Akiko Morimoto; Yukako Tatsumi; Nao Sonoda; Naomi Miyamatsu; Tetsuo Shimoda; Shiro Sakaguchi
Journal:  Diabetol Int       Date:  2016-09-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.